Ironwood Pharmaceuticals | Les Charges D'Exploitation



Operating Expenses Changement Date
Acadia Pharmaceuticals USD 225.03M 118.93M 2025-03
Agios Pharmaceuticals USD 115.35M 20.41M 2025-03
Almirall EUR 485.13M 289.74M 2024-12
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Amarin USD 67.47M 549K 2024-09
Ardelyx USD 108M 12M 2024-12
Astellas Pharma JPY 395.77B 237.82B 2025-03
AstraZeneca USD 9.91B 2.94B 2025-03
Charles River Laboratories USD 909.5M 260.74M 2025-03
Exact Sciences USD 802.8M 786.98M 2025-03
Halozyme Therapeutics USD 123.33M 819K 2025-03
Incyte USD 847.73M 29.46M 2025-03
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
MacroGenics USD 35.94M 20.58M 2024-12
Moderna USD 1.16B 1.06B 2025-03
Myriad Genetics USD 224.9M 24.7M 2025-03
Pacira USD 166.93M 4.38M 2025-03
PTC Therapeutics USD 205.87M 69.79M 2025-03
Sarepta Therapeutics USD 1.05B 548.51M 2025-03
Takeda JPY 1.13T 51.15B 2025-03
Ultragenyx Pharmaceutical USD 282.23M 4.92M 2025-03



Ironwood Pharmaceuticals Les Charges D'Exploitation - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.